Cargando…

An overview of preclinical animal models for SARS-CoV-2 pathogenicity

Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 has caused millions of fatalities globally since its origin in November 2019. The SARS-CoV-2 shares 79 and 50 per cent genome similarity with its predecessors, severe SARS-CoV and Middle East respiratory syndrome (MERS) coronavirus, all belo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Munshi, Itti, Khandvilkar, Aditya, Chavan, Shrinivas M., Sachdeva, Geetanjali, Mahale, Smita D., Chaudhari, Uddhav K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184076/ https://www.ncbi.nlm.nih.gov/pubmed/33818465 http://dx.doi.org/10.4103/ijmr.IJMR_3215_20

Ejemplares similares

An Overview of SARS-CoV-2 and Animal Infection
por: Mahdy, Mohamed A. A., et al.
Publicado: (2020)

sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection
por: Jagtap, Dhanashree, et al.
Publicado: (2021)

Overview of lasers
por: Patil, Uddhav A., et al.
Publicado: (2008)

Transmissibility and pathogenicity of SARS-CoV-2 variants in animal models
por: Kim, Young-Il, et al.
Publicado: (2022)

Detection of SARS-CoV-2 infection by RT-PCR test: factors influencing interpretation of results
por: Munne, Kiran, et al.
Publicado: (2021)

Universal screening identifies asymptomatic carriers of SARS-CoV-2 among pregnant women in India
por: Waghmare, Rakesh, et al.
Publicado: (2021)

Co‐infection of malaria and dengue in pregnant women with SARS‐CoV‐2
por: Mahajan, Niraj N., et al.
Publicado: (2020)

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models
por: Ku, Min-Wen, et al.
Publicado: (2021)

Development of Inactivated FAKHRAVAC(®) Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models
por: Ghasemi, Soheil, et al.
Publicado: (2021)

Delirium in a pregnant woman with SARS-CoV-2 infection in India
por: Mahajan, Niraj N., et al.
Publicado: (2021)

Postpartum psychosis in mothers with SARS-CoV-2 infection: A case series from India
por: Subramanyam, Alka A., et al.
Publicado: (2020)

How many animals are used for SARS‐CoV‐2 research?: An overview on animal experimentation in pre‐clinical and basic research
por: Schwedhelm, Philipp, et al.
Publicado: (2021)

Impact of SARS‐CoV‐2 on multiple gestation pregnancy
por: Mahajan, Niraj N., et al.
Publicado: (2020)

Infectivity, virulence, pathogenicity, host-pathogen interactions of SARS and SARS-CoV-2 in experimental animals: a systematic review
por: Sarkar, Jayanta, et al.
Publicado: (2020)

SARS-CoV-2 pandemic: An overview
por: Acuti Martellucci, Cecilia, et al.
Publicado: (2020)

Prophylaxis and treatment of SARS-CoV-2 infection by an ACE2 receptor decoy in a preclinical animal model
por: Tada, Takuya, et al.
Publicado: (2023)

Preclinical Testing in Translational Animal Models of Prader-Willi Syndrome: Overview and Gap Analysis
por: Carias, K. Vanessa, et al.
Publicado: (2019)

Seroprevalence of anti-SARS-CoV-2 of IgG antibody by ELISA: Community-based, cross-sectional study from urban area of Malegaon, Maharashtra
por: Saple, Pallavi, et al.
Publicado: (2021)

SARS-CoV-2 ORF7a potently inhibits the antiviral effect of the host factor SERINC5
por: Timilsina, Uddhav, et al.
Publicado: (2022)

Single-epitope T cell–based vaccine protects against SARS-CoV-2 infection in a preclinical animal model
por: Tada, Takuya, et al.
Publicado: (2023)

An Overview of the Crystallized Structures of the SARS-CoV-2
por: Ionescu, Mihaela Ileana
Publicado: (2020)

The SARS-CoV-2 Vaccine Pipeline: an Overview
por: Chen, Wen-Hsiang, et al.
Publicado: (2020)

SARS-CoV-2 aerosol and droplets: an overview
por: Ranga, Udaykumar
Publicado: (2021)

Investigation of Animal Reservoir(s) of SARS-CoV
por: Hu, Zhihong, et al.
Publicado: (2008)

Animal models for SARS-CoV-2
por: Lee, Chung-Young, et al.
Publicado: (2021)

SARS-CoV-2 Vaccine Development: An Overview and Perspectives
por: Liu, Yi, et al.
Publicado: (2020)

SARS CoV-2: Progression and treatment protocols – An overview
por: Krishnan, Hareesh, et al.
Publicado: (2021)

An overview of the gut side of the SARS-CoV-2 infection
por: Barbosa da Luz, Bruna, et al.
Publicado: (2021)

Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview
por: Shiravi, Amir Abbas, et al.
Publicado: (2021)

Overview of SARS-CoV-2 genome-encoded proteins
por: Bai, Chongzhi, et al.
Publicado: (2021)

SARS-CoV-2 and Acute Cerebrovascular Events: An Overview
por: Ghasemi, Mehdi, et al.
Publicado: (2021)

An Overview of SARS-CoV-2 Molecular Diagnostics in Europe
por: Davies, Emma, et al.
Publicado: (2022)

SARS-CoV-2 Infection and Taste Alteration: An Overview
por: Scotto, Gaetano, et al.
Publicado: (2022)

Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models
por: Banihashemi, Seyed Reza, et al.
Publicado: (2022)

Preclinical data from SARS-CoV-2 mRNA vaccine
por: Vabret, Nicolas
Publicado: (2020)

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies
por: Kandeil, Ahmed, et al.
Publicado: (2021)

Preclinical study of a DNA vaccine targeting SARS-CoV-2
por: Hayashi, Hiroki, et al.
Publicado: (2022)

Preclinical Establishment of a Divalent Vaccine against SARS-CoV-2
por: Hevesi, Zsofia, et al.
Publicado: (2022)

P.150 SARS-CoV-2 causing septic shock in pregnancy
por: Roach, M.T., et al.
Publicado: (2021)

Delineating the Structure–Dynamics–Binding Differences among BA.1, BA.4/5, and BF.7 SARS-CoV-2 Variants through Atomistic Simulations: Correlation with Structural and Epidemiological Features
por: Joshi, Aryaman, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cmrptherj9vmc5fe8ie229vd9u